Tag: GENOMICS
Quantum Genomics ready to restart in 2024 after a year of “refoundation” – 03/13/2024 at 6:27 p.m.
(AOF) – Quantum Genomics posts a net loss of 3.2 million euros as of December 31, 2023. The medtech has available cash of 3.50 million euros as of December 31,…
Quantum Genomics ready to restart in 2024 after a year of “refoundation”
(AOF) – Quantum Genomics posts a net loss of 3.2 million euros as of December 31, 2023. The medtech has available cash of 3.50 million euros as of December 31,…
Quantum Genomics in exclusive negotiations with ExactCure – 12/14/2023 at 6:16 p.m.
(AOF) – Quantum Genomics announces that it has entered into exclusive negotiations with a view to a merger with ExactCure, a French company developing an artificial intelligence device making it…
Quantum Genomics breaks off negotiations with Vistacare Medical – 10/17/2023 at 6:29 p.m.
(AOF) – Quantum Genomics announces that it is ending the exclusive negotiation initiated with Vistacare Medical and announced on July 20. The biotech specialist in cardiovascular diseases believes that “the…
Quantum Genomics breaks off negotiations with Vistacare Medical
(AOF) – Quantum Genomics announces that it is ending the exclusive negotiation initiated with Vistacare Medical and announced on July 20. The biotech specialist in cardiovascular diseases believes that “the…
Quantum Genomics in exclusive negotiations with Vistacare – 2023-07-20 at 18:13
(AOF) – Quantum Genomics has entered into exclusive negotiations with Vistacare Medical with the ambition of creating “a benchmark player in the management of complex wounds”. Vistacare is an unlisted…
Quantum Genomics in exclusive negotiations with Vistacare
(AOF) – Quantum Genomics has entered into exclusive negotiations with Vistacare Medical with the ambition of creating “a benchmark player in the management of complex wounds”. Vistacare is an unlisted…
QUANTUM GENOMICS: Quantum Genomics announces that it has taken a new step in its strategic redeployment – 04/05/2023 at 18:00
Quantum Genomics announces that it has taken a new step in its strategic redeployment Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), currently in full strategic redeployment, announced that it…
Quantum Genomics: advanced discussions with a partner
(CercleFinance.com) – Currently in the midst of a strategic redeployment, Quantum Genomics announced last night that it had entered into advanced discussions with a company whose skills are complementary to…
QUANTUM GENOMICS: Quantum Genomics announces a reshuffle of its Board of Directors and a restructuring of its workforce to focus on new projects – 02/22/2023 at 18:00
Quantum Genomics Announces Reshuffle of its Board of Directors and Restructuring of its Workforce to Focus on New Projects Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company…
Quantum Genomics revokes its historic boss and abandons firibastat in cardiology – 02/22/2023 at 18:21
(AOF) – Quantum Genomics, a biotech developing drugs that act directly on the brain, announces that its managing director since 2018 Jean-Philippe Milon has also been appointed chairman of the…
QUANTUM GENOMICS: Progress report – 08/12/2022 at 18:00
Waypoint Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new class of drugs that act directly on the brain, provides an…